| Literature DB >> 35329513 |
Chaochao Zhao1,2, Yuan Yang2,3, Xi Cui2,3, Yizhu Shan2,3, Jiangtao Xue2,4, Dongjie Jiang2,3, Jinyan Sun1, Na Li1, Zhou Li2,3, Anping Yang1.
Abstract
Oral squamous cell carcinoma (OSCC) is a common oral cancer of the head and neck, which causes tremendous physical and mental pain to people. Traditional chemotherapy usually results in drug resistance and side effects, affecting the therapy process. In this study, a self-powered electrical impulse chemotherapy (EIC) method based on a portable triboelectric nanogenerator (TENG) was established for OSCC therapy. A common chemotherapeutic drug, doxorubicin (DOX), was used in the experiment. The TENG designed with zigzag structure had a small size of 6 cm × 6 cm, which could controllably generate the fixed output of 200 V, 400 V and 600 V. The electrical impulses generated by the TENG increased the cell endocytosis of DOX remarkably. Besides, a simply and ingeniously designed microneedle electrode increased the intensity of electric field (EF) between two adjacent microneedle tips compared with the most used planar interdigital electrode at the same height, which was more suitable for three-dimensional (3D) cells or tissues. Based on the TENG, microneedle electrode and DOX, the self-powered EIC system demonstrated a maximal apoptotic cell ratio of 22.47% and a minimum relative 3D multicellular tumor sphere (MCTS) volume of 160% with the drug dosage of 1 μg mL-1.Entities:
Keywords: electrical impulse chemotherapy; oral squamous cell carcinoma; self-powered; triboelectric nanogenerator
Year: 2022 PMID: 35329513 PMCID: PMC8954269 DOI: 10.3390/ma15062060
Source DB: PubMed Journal: Materials (Basel) ISSN: 1996-1944 Impact factor: 3.623
Figure 1The working principle and output performance of the output controllable triboelectric nanogenerator (TENG). (a) The physical pictures of the TENG. (b) The schematic picture of the TENG. (c) The scanning electron microscope (SEM) image of the polytetrafluoroethylene (PTFE) surface. (d) The working principle of the fabricated TENG. (e) The Voc and Isc when two polyethylene terephthalate (PET) layers were working. (f) The Voc and Isc when three PET layers were working. (g) The Voc and Isc when four PET layers were working.
Figure 2The self-powered electrical impulse chemotherapy (EIC) to treat 2D Tca-8113 cells. (a) The 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay of different doxorubicin (DOX) concentrations. (b) The cell viabilities of Tca-8113 cells in the control, 600 V, DOX + 200 V, DOX + 400 V and DOX + 600 V groups. (c–e) The live and dead images of Tca-8113 cells in different groups. The microscope photos of the control group (f) and the DOX + 600 V group (g). The fluorescence microscope photographs of the DOX group (h) and the DOX + 600 V group. Scale bar: 100 μm (i).
Figure 3The fabrication of the microneedle electrode. (a) The manufacturing process of the microneedle electrode. (b) The digital picture of the fabricated microneedle electrode. (c) The optical microscope image of the microneedles. (d) The SEM image of the microneedles. The finite element analysis of the microneedle electrode (e) and the planar electrode (f) with the voltage of 600 V.
Figure 4The self-powered EIC to treat 3D multicellular tumor sphere (MCTS) system. (a) The schematic diagram of the microneedle electrodes and MCTSs. (b) The proportions of apoptotic cell calculated in the TUNEL experiment, p values: ** p < 0.01. (c) The TUNEL images in the control, 600 V, DOX and DOX + 600 V groups. Scale bar: 100 μm. (d) The volume growth of Tca-8113 MCTSs in different groups (n = 4).